A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to eliminate biopsies used to diagnose certain anosmia conditions and to aid in the development of therapeutic interventions. This research, funded in part by NIBIB, was published in the August issue of The Journal of Nuclear Medicine.

Source: Society of Nuclear Medicine and Molecular Imaging News